HALOZYME THERAPEUTICS, INC.
HALO나스닥Biological Products, (No Diagnostic Substances)US미국
30일 공시 수
2건
최근 2026.10.08
90일 내부자 순매수
-219억원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 11건
- US미국임원·주요주주 소유중요도 높음2026.10.084 · Statement of changes in beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 4 · 2026.10.08
- US미국임원·주요주주 소유중요도 낮음2026.10.08정정4/A · Statement of changes in beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 4/A · 2026.10.08
- US미국임원·주요주주 소유중요도 낮음2026.10.024 · Statement of changes in beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 4 · 2026.10.02
- US미국임원·주요주주 소유중요도 보통2026.10.024 · Statement of changes in beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 4 · 2026.10.02
- US미국임원·주요주주 소유중요도 낮음2026.10.023 · Initial statement of beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 3 · 2026.10.02
- US미국지배구조·주총중요도 보통2026.10.018-K · Current report (Items 5.02)
HALOZYME THERAPEUTICS, INC.HALO
8-K · 2026.10.01 05:20 KST
- US미국증자·자금조달중요도 높음2026.09.238-K · Current report (Items 1.01, 2.03, 3.02, 9.01)
HALOZYME THERAPEUTICS, INC.HALO
8-K · 2026.09.23 05:41 KST
- US미국주요사항·수시공시중요도 낮음2026.09.188-K · Current report (Items 8.01, 9.01)
HALOZYME THERAPEUTICS, INC.HALO
8-K · 2026.09.18 21:23 KST
- US미국임원·주요주주 소유중요도 높음2026.09.174 · Statement of changes in beneficial ownership
HALOZYME THERAPEUTICS, INC.HALO
Form 4 · 2026.09.17
- US미국주요사항·수시공시중요도 낮음2026.09.178-K · Current report (Items 8.01, 9.01)
HALOZYME THERAPEUTICS, INC.HALO
8-K · 2026.09.17 05:32 KST